Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suzanne Salazar"'
Autor:
Geoffrey Lowman, Harwinder Sidhu, John Williamson, Suzanne Salazar, Timothy Looney, Luis Solano, Huan Tian, Rajendra Ramsamooj
Publikováno v:
Blood. 134:5774-5774
Introduction: The ability to detect and quantitate low frequency T-cell clones enables numerous hematology/oncology research applications, including identification and assessment of biomarkers associated minimal residual disease (MRD). Rare clone det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3071edb2911fd481c5049fa4ee686f10
https://doi.org/10.1182/blood-2019-127459
https://doi.org/10.1182/blood-2019-127459
Autor:
David Seidman, Suzanne Salazar, John Williamson, Tommie Lincecum, Seth Sadis, Xia Li, Christine Chin, Haigang Gu, Janet Orton, Guang Liu, Tabetha Sundin, Thomas Ha
Publikováno v:
Journal of Clinical Oncology. 37:e14603-e14603
e14603 Background: MET is the target of recurrent somatic alterations in approximately 7% of non-small cell lung carcinomas (NSCLC). A key class of therapeutically relevant MET mutations results in aberrant mRNA splicing, deletion of exon 14 from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35f2e290e1b4a78e754a4035109ae801
https://doi.org/10.1200/jco.2019.37.15_suppl.e14603
https://doi.org/10.1200/jco.2019.37.15_suppl.e14603
Autor:
Kimberly McCall, Angie Cheng, Vanessa D. Burkhart, Hannah E. Saunders, John Williamson, Cecilia Ojcius, Akemi Yuki, James L. Chitwood, Ru Cao, Roxana White, Huan Tian, Luis Solano, Kelli Bramlett, Thomas Ha, Jeoffrey Schageman, Rajendra Ramsamooj, Suzanne Salazar
Publikováno v:
Journal of Clinical Oncology. 37:e14614-e14614
e14614 Background: Assessing tumor-derived somatic variants from blood plasma provides minimally invasive tumor profiling, decreased cost relative to traditional tissue biopsy and rapid turn-around-time. We describe here the analytical validation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d91940ebef2df6e77741741f6edad53
https://doi.org/10.1200/jco.2019.37.15_suppl.e14614
https://doi.org/10.1200/jco.2019.37.15_suppl.e14614
Autor:
Kristen M.N. Vandewalker, Suzanne Salazar, Harwinder Sidhu, Damion Whitfield, John Williamson
Publikováno v:
Journal of Clinical Oncology. 36:e24200-e24200
e24200Background: Immune-oncology has the potential to significantly advance our understanding of cancer biology. The ability to rapidly assess cancer-relevant gene expression (GEx) profiles using ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3b5312f1d0db20c3e3ea2a146092676
https://doi.org/10.1200/jco.2018.36.15_suppl.e24200
https://doi.org/10.1200/jco.2018.36.15_suppl.e24200
Autor:
Lisa Uyeda, James M Atkins, Joanna Roder, Kurt W. Tauer, Krista Meyer, Vipul M. Patel, Mark A. Socinski, Bruno R. Bastos, David R. Spigel, Paul J. E. Miller, Corey J. Langer, Suzanne Salazar, Lee S. Schwartzberg, Mark S. Walker, Kulumani M Sivarajan
Publikováno v:
Journal of Clinical Oncology. 31:8044-8044
8044 Background: The eLung trial randomized chemotherapy naïve advanced NSCLC patients (pts) to 1 of 3 PD and concurrent CET followed by CET maintenance until progression, stratified by non-squamous (NSQ) and squamous (SQ) histology. Primary outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7c68e055216930bf79deb4fa78fe3f6
https://doi.org/10.1200/jco.2013.31.15_suppl.8044
https://doi.org/10.1200/jco.2013.31.15_suppl.8044